Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Testing Likely Cost-Effective for Suspected Glomerular Kidney Diseases Among Australian Patients

In a study appearing in Genetics in Medicine, researchers from the University of Melbourne evaluate the cost-effectiveness of genomic testing compared with standard non-genomic diagnostic methods in Australian patients with suspected monogenic kidney diseases. While nephrologists recognize the clinical benefits of genomic testing, the authors say access to testing could be more equitable. The researchers used diagnostic and clinical information from an Australian cohort of 349 individuals and developed a model that captured diagnostic, health, and economic outcomes from clinical presentation until three months post-test results. Genomic testing was AU$1,600 more costly per patient and led to an additional 27 diagnoses out of 100 individuals tested, resulting in an incremental cost-effectiveness ratio of AU$5,991 per additional diagnosis, the researchers report. Additionally, genomic testing resulted in an further cost of AU$438 and 0.04 quality-adjusted life year gained per individual, compared with standard diagnostic investigations. The authors concluded that genomic testing is likely cost-saving for individuals with suspected glomerular diseases, however, the same wasn't observed for non-glomerular conditions.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.